Balentine LLC’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-65
Closed -$4K – 672
2019
Q4
$4K Buy
+65
New +$3.53K ﹤0.01% 479
2018
Q1
– Sell
-50
Closed -$2K – 197
2017
Q4
$2K Hold
50
– – ﹤0.01% 595
2017
Q3
$2K Hold
50
– – ﹤0.01% 603
2017
Q2
$2K Hold
50
– – ﹤0.01% 573
2017
Q1
$2K Hold
50
– – ﹤0.01% 544
2016
Q4
$2K Hold
50
– – ﹤0.01% 477
2016
Q3
$2K Hold
50
– – ﹤0.01% 431
2016
Q2
$2K Hold
50
– – ﹤0.01% 429
2016
Q1
$2K Hold
50
– – ﹤0.01% 316
2015
Q4
$1K Hold
50
– – ﹤0.01% 402
2015
Q3
$2K Hold
50
– – ﹤0.01% 441
2015
Q2
$2K Hold
50
– – ﹤0.01% 366
2015
Q1
$2K Buy
+50
New +$1.71K ﹤0.01% 328

Other funds holding EHC

Balentine LLC's EHC Position: Q1 2020 in Review

Balentine LLC sold out of Encompass Health (EHC) in Q1 2020, closing a stake of 65 shares — an estimated $4K sold.

Balentine LLC first reported a position in EHC in Q1 2015 and held it in 13 quarters. The position peaked at $4K in Q4 2019. 374 funds tracked by Wall St. Rank hold EHC as of Q1 2020.

  • Balentine LLC reported no remaining Encompass Health position as of Q1 2020 after selling out during the quarter.
  • Balentine LLC sold 65 Encompass Health shares in Q1 2020, an estimated $4K.
  • Balentine LLC first reported a position in Encompass Health in Q1 2015 and held it in 13 quarters.
  • Balentine LLC's Encompass Health position peaked at $4K in Q4 2019.
  • 374 funds tracked by Wall St. Rank held Encompass Health as of Q1 2020.

Based on Balentine LLC's 13F filing for Q1 2020, filed 18 May 2020.